Reuters is looking for an ambitious U.S. Pharmaceutical Industry Reporter with a track record of scoops and agenda-setting stories. The successful candidate will break news on an industry that has benefited tremendously, both in terms of profit and influence, from developing vaccines and treatments critical to alleviating the COVID pandemic. At the same time, the industry is fending off efforts to curb the rising costs of prescription medicines and faces increasing pushback from national regulators over drug approvals.This reporter would break news on how companies like Pfizer and Moderna will spend the billions of dollars earned off the pandemic, including a new push for acquisitions after a long hiatus. The candidate will report on how the pharma industry is exercising its enhanced leverage with governments, in Washington and abroad, seeking to sway major policy decisions on how drugs are approved and priced, from insulin to Alzheimer’s treatments.